MIDLAND ? Gregg Zank, Chief Technology Officer and Executive Director of Science & Technology for Dow Corning is the luncheon keynote speaker Thursday at a conference that will explore where Life Sciences is headed in Michigan.
Just before lunch, Timothy Mayleben, Chief Operating Officer & CFO of Esperion Therapeutics, which was acquired last year for $1.3 billion by Pfizer, will talk about Esperion, what has become the poster child for successful Life Sciences innovation in the state.
The day-long event provides access to executives and educators from Dow Chemical, Dow Corning, Michigan State University, Central Michigan University and Saginaw Valley State University and major life-sciences organizations, including MichBio and the Michigan Molecular Institute. Registration starts at 8 am and the event concludes at 2:30 p.m. The cost is $35, which includes lunch. For further details, click on The Glance.Com in the Mitechnews.Com navigation bar.
Here?s the entire agenda:
MID TECH: LIFE SCIENCES AND BEYOND
8:00- 8:25: Registration and Networking
8:30 – 8:40: Welcome & Introduction
Introduction: Jen�e L. Velasquez, Executive Director, Midland Tomorrow;
Welcome: Don Taylor, Supply Chain Director, Performance Chemicals & Thermosets, & Site Leader, The Dow Chemical Company;
Few Words: Herbert D. (?Ted?) Doan, Chairman of the Board, The Herbert H. & Grace A. Dow Foundation
8:40 – 9:00: New Technologies and Emerging Opportunities
Speaker: Paul M. Hunt, Associate Vice President, Research and Graduate Studies, MSU
9:00 – 9:45: Creating Value Through Growth: Spotting the Opportunity
Moderator: Michael D. Witt, Executive Director, MICHBIO;
Panelists: Peter Dulcamara, Senior Director of R&D, Technology Licensing & Catalyst, The Dow Chemical Company;
John W. Frost, Professor of Chemistry, Michigan State University;
Linda D. Kennan, Director of Science and Technology, Life Sciences Industry, Dow Corning Corporation;
Robert Nowak, President and CEO, Michigan Molecular Institute
9:45 – 10:15: Case Study: Nephros Therapeutics, Inc.
Speaker: H. David Humes, Founder and Chief Science Officer, Nephros Therapeutics, Inc.
10:15-10:30: Break and Networking
10:30-11:15: Current Life Science Funding Trends
Moderator: Hugo Braun, General Partner, North Coast Technology Investors, LP;
Panelists: Tino Breithaupt, Vice President, Michigan Technology Tri Corridor, MEDC;
Stephen E. Gosney, Director of Innovation, Life Sciences Business, Dow Corning Corporation;
Timothy B. Petersen, Managing Partner, Arboretum Ventures;
James H. Plonka, Vice President, Venture Capital, The Dow Chemical Company
11:15 – 11:45: Case Study: Esperion Therapeutics, Inc.
Speaker: Timothy M. Mayleben, Chief Operating Officer & CFO, Esperion Therapeutics, Inc., acquired by Pfizer Inc.
11:45 – 12:30: Lunch
12:30 – 1:05: Innovation and Growth in Life Sciences: A Dow Corning Perspective
Speaker: Gregg A. Zank, Chief Technology Officer and Executive Director of Science & Technology, Dow Corning Corporation
1:05 – 1:15 Break and Networking
1:15 – 1:45 Innovation and Growth In Life Sciences: An Academic Perspective
Speaker: John W. Frost, Professor of Chemistry, Michigan State University
1:45 – 2:30 Bridging the Gap: Start-Up and Growth Resources
Moderator: TBD
Panelists: Brent Case, Technology Business Development Manager, Central Michigan University;
Lorraine (Lori) J. Hudson, Director, Office of Intellectual Property, Michigan State University;
Diana R. Lawson, Harvey Wickes Chair of International Business, Saginaw Valley State University;
Christine M. Greve, Regional Director of MI-SBTDC Region 5
2:30 – 2:35: Concluding Remarks
Speaker: Jen�e L. Velasquez, Executive Director, Midland Tomorrow
